$5.63
-0.30[-5.06%]
Last update: 3:33PM Get Real Time Here
Replimune Group: Insider buying and selling updated today.
May 20, 2024 | Christopher Sarchi | CHIEF COMMERCIAL OFFICER | -2.218K | $6.47 | -$14.35K | SELL | -2.35% | 92.252K | May 16 | View |
May 20, 2024 | Andrew Schwendenman | CHIEF ACCOUNTING OFFICER | -2.298K | $6.47 | -$14.87K | SELL | -5.67% | 38.238K | May 16 | View |
May 20, 2024 | Colin Love | CHIEF OPERATING OFFICER | -17.615K | $6.47 | -$113.97K | SELL | -2.22% | 777.345K | May 16 | View |
May 20, 2024 | Philip AstleySparke | EXECUTIVE CHAIRMAN | -37.928K | $6.47 | -$245.39K | SELL | -2.49% | 1.48735M | May 16 | View |
May 20, 2024 | Robert Coffin | DIRECTOR | -11.464K | $6.47 | -$74.17K | SELL | -0.63% | 1.821872M | May 16 | View |
May 20, 2024 | Sushil Patel | CHIEF EXECUTIVE OFFICER | -20.194K | $6.47 | -$130.66K | SELL | -8.70% | 212.014K | May 16 | View |
May 20, 2024 | Konstantinos Xynos | CHIEF MEDICAL OFFICER | -6.367K | $6.47 | -$41.19K | SELL | -4.57% | 133.012K | May 16 | View |
Nov 17, 2023 | Konstantinos Xynos | CHIEF MEDICAL OFFICER | -7.313K | $10.92 | -$79.86K | SELL | -6.09% | 112.714K | Nov 16 | View |
Nov 17, 2023 | Christopher Sarchi | CHIEF COMMERCIAL OFFICER | -5.255K | $10.92 | -$57.38K | SELL | -6.78% | 72.245K | Nov 16 | View |
Sep 13, 2023 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0 | $11.65 | -$94.54K | SELL-OPTIONS | 0.00% | 263.436K | Sep 11 - Sep 12 | View |
Aug 24, 2023 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0 | $13.29 | -$249.81K | SELL-OPTIONS | 0.00% | 263.436K | Aug 22 | View |
Aug 15, 2023 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0 | $11.65 | -$23.38K | SELL-OPTIONS | 0.00% | 263.436K | Aug 11 | View |
Jul 11, 2023 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0 | $13.96 | -$304.54K | SELL-OPTIONS | 0.00% | 263.436K | Jul 10 | View |
Jun 15, 2023 | Tanya Lewis | CHIEF DEV. OP. OFFICER | -12.86K | $24.06 | -$309.39K | SELL | -8.68% | 135.293K | Jun 13 | View |
Jun 15, 2023 | Sushil Patel | CHIEF STRATEGY OFFICER | -5.698K | $24.04 | -$137.01K | SELL | -3.69% | 148.873K | Jun 13 | View |
May 18, 2023 | Sushil Patel | CHIEF STRATEGY OFFICER | -15.575K | $18.05 | -$281.13K | SELL | -9.15% | 154.571K | May 16 | View |
May 18, 2023 | Robert Coffin | PRESIDENT & CHIEF R&D OFFICER | -7.861K | $18.05 | -$141.89K | SELL | -0.43% | 1.833336M | May 16 | View |
May 18, 2023 | Tanya Lewis | CHIEF DEV. OP. OFFICER | -12.207K | $18.05 | -$220.34K | SELL | -7.61% | 148.153K | May 16 | View |
May 18, 2023 | Colin Love | CHIEF OPERATING OFFICER | -10.775K | $18.05 | -$194.49K | SELL | -1.34% | 794.96K | May 16 | View |
May 18, 2023 | Jean Franchi | CHIEF FINANCIAL OFFICER | -11.351K | $18.05 | -$204.89K | SELL | -8.10% | 128.748K | May 16 | View |
May 18, 2023 | Konstantinos Xynos | CHIEF MEDICAL OFFICER | -771 | $18.05 | -$13.92K | SELL | -0.64% | 120.027K | May 16 | View |
May 18, 2023 | Pamela Esposito | CHIEF BUSINESS OFFICER | -5.966K | $18.05 | -$107.69K | SELL | -2.21% | 263.436K | May 16 | View |
May 18, 2023 | Philip AstleySparke | CHIEF EXECUTIVE OFFICER | -17.902K | $18.05 | -$323.13K | SELL | -1.16% | 1.525278M | May 16 | View |
Dec 13, 2022 | Pamela Esposito | CHIEF BUSINESS OFFICER | 0 | $13.02 | -$360.30K | SELL-OPTIONS | 0.00% | 229.402K | Dec 09 | View |
May 18, 2022 | Colin Love | CHIEF OPERATING OFFICER | -6.324K | $14.59 | -$92.27K | SELL | -0.82% | 765.735K | May 16 | View |
May 18, 2022 | Pamela Esposito | CHIEF BUSINESS OFFICER | -3.507K | $14.59 | -$51.17K | SELL | -1.51% | 229.402K | May 16 | View |
May 18, 2022 | Jean Franchi | CHIEF FINANCIAL OFFICER | -3.436K | $14.59 | -$50.13K | SELL | -3.49% | 95.099K | May 16 | View |
May 18, 2022 | Tanya Lewis | CHIEF DEV. OP OFFICER | -5.473K | $14.59 | -$79.85K | SELL | -4.35% | 120.36K | May 16 | View |
May 18, 2022 | Sushil Patel | CHIEF COMMERCIAL OFFICER | -10.687K | $14.59 | -$155.92K | SELL | -7.59% | 130.146K | May 16 | View |
May 18, 2022 | Robert Coffin | PRESIDENT & CHIEF R&D OFFICER | -5.737K | $14.59 | -$83.70K | SELL | -0.32% | 1.796197M | May 16 | View |
Browse insider trades on all stocks.